Individual inert ingredient approvals starting on February 1, 2024, can be found in the table below. Historical approvals prior to this date can be found on InertFinder. Food use approvals designated ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
A thyroid medicine is being recalled at the FDA's highest risk level − and it's causing confusion and concern among the many Americans who use such medications to manage thyroid conditions. The recall ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
- Expands complex injectables portfolio with important long-acting oncology treatment - Immediate commercial launch supported by in-house production BRIDGEWATER, N.J., Sept. 18, 2026 (GLOBE NEWSWIRE) ...
The U.S. Environmental Protection Agency (EPA) is registering the new active ingredient glufosinate-P that controls weeds in conventional and glufosinate-resistant field corn, sweet corn, soybean, ...
Brigham and Women's nurses postponed the Oct. 14 strike to vote on a final offer. See the pay, insurance, and staffing terms, and what patients face. Parents Should Check Amazon Bath Seats and ...
Manoj Joshi, secretary, Department of Pharmaceuticals (DoP), Government of India, visited Amneal Pharmaceuticals’ corporate office in Ahmedabad and met with company leaders to discuss Amneal’s growth, ...
Amneal Pharmaceuticals received approval from the Food and Drug Administration for lanreotide, a generic brand of a treatment for hormonal diseases. The product, which will launch immediately, was ...
US-based pharmaceutical company Amneal Pharmaceuticals is expanding its capabilities in India following its acquisition of Kashiv BioSciences, bringing together a larger platform for biosimilars, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results